Current Pediatric Reviews
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 4
Author(s): J. A. Bellanti
Affiliation:
Export Options
About this article
Cite this article as:
Bellanti A. J., Meet Our Editorial Board Member, Current Pediatric Reviews 2016; 12 (4) . https://dx.doi.org/10.2174/157339631204161214211943
DOI https://dx.doi.org/10.2174/157339631204161214211943 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders α7 nAChR in Airway Respiratory Epithelial Cells
Current Drug Targets Effect of Nutrient Medium, Phytohormones and Elicitation Treatment on in-vitro Callus Culture of Bacopa monniera and Expression of Secondary Metabolites
The Natural Products Journal Novel Approaches for Inhibition of Mucus Hypersecretion in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Covid-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management
Current Molecular Pharmacology Antimicrobial Potential of Botanicals and Disease Control
The Natural Products Journal Nanotechnology can Provide Therapeutic Agent by Targeting Molecular Structures of SARS-CoV-2 (COVID-19): A Mini-Review
Letters in Drug Design & Discovery Green Synthesis of Well Dispersed Nanoparticles using Leaf Extract of Medicinally useful Adhatoda Vasica Nees
Micro and Nanosystems Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Current Pharmaceutical Design Human Ascariasis: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Identification of Genes for a Complex Trait: Examples from Hypertension
Current Pharmaceutical Biotechnology Comprehensive Account on the Synthesis of (-)-Balanol and its Analogues
Current Organic Synthesis Pt2L4 Protein, a Homologue to Hev b 5 from Rubber Tree, May Not Be Responsible for the Cross-Reactions to Cassava Show by People Allergic to Latex
Protein & Peptide Letters Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets Patent Selections
Recent Patents on Drug Delivery & Formulation Molecular Targets for Modulating Lung Inflammation and Injury
Current Drug Targets Amygdalin Decreases Adhesion and Migration of MDA-MB-231 and MCF-7 Breast Cancer Cell Lines
Current Molecular Pharmacology